Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Hematology

Building Your Care Team and Preparing for Visits

At a Glance

People with monoclonal mast cell activation syndrome benefit from coordinated care involving hematology and allergy and immunology. Bring tryptase, KIT, pathology, and reaction records to specialist visits, and plan surgery with the anesthesiologist and allergist in advance.

Managing Monoclonal Mast Cell Activation Syndrome (MMAS) is a team effort. Because it involves both a clonal population of cells and the unpredictable release of inflammatory chemicals, it doesn’t fit neatly into just one medical specialty. Instead, it requires a coordinated approach between specialists who understand the cellular biology and those who understand the clinical reactions [1][2].

Building Your Care Team

Most patients with MMAS benefit from a multidisciplinary team, ideally guided by experts at a mastocytosis reference center. These centers have the specialized equipment and expertise needed to manage rare clonal disorders [3][4].

The Hematologist

The hematologist focuses on the “clonality” of your condition. They are responsible for:

  • Bone Marrow Evaluation: Interpreting the pathology of your bone marrow, including looking for the KIT D816V mutation and markers like CD25 [5][6].
  • Monitoring Progression: Checking for signs that MMAS might be transitioning or changing clinically over time [3].
  • Blood Counts: Monitoring your overall blood health to ensure no other hematologic issues are developing [6].

The Allergist/Immunologist

The allergist focuses on the mediators (chemicals) released by those cells and emergency safety. Their role includes:

  • Anaphylaxis Management: Creating your emergency action plan and prescribing the correct amount of epinephrine [7].
  • Venom Specialty: Managing testing and Venom Immunotherapy (VIT) if you have insect sting allergies [8].
  • Symptom Control: Titrating daily antihistamines and other preventative medications [7].

Perioperative Care and Anesthesiology

Surgical procedures pose a specific risk for patients with mast cell disorders. It is vital that your care team includes the anesthesiologist and surgical team prior to any procedure. They must coordinate with your allergist to create an individualized perioperative plan detailing observation, rescue treatments, and safe anesthetic choices [9][10]. Do not self-premedicate or alter your medications before surgery without explicit medical direction.

Other Key Specialists

Depending on your symptoms, your team may also include:

  • Hematopathologist: The expert who looks at your bone marrow tissue under a microscope. Having a hematopathologist specifically trained in mast cell disorders is vital; one study found that up to 23% of initial diagnoses were incorrect before an expert review [11].
  • Gastroenterologist: For persistent stomach pain or digestive issues [12].
  • Endocrinologist: To manage bone health and osteoporosis screening [13].
  • Primary Care Provider: To ensure all aspects of your general health are maintained alongside your specialist care.

Preparing for Your First Expert Visit

The first visit with a mast cell expert can be overwhelming. Bringing an organized “packet” of your history allows the doctor to focus on your care rather than hunting for data [6].

Essential Records to Bring

  • The Tryptase Log: A table of every tryptase test you’ve had. Clearly mark which were “baseline” (when feeling well) and which were “acute” (during or immediately after a reaction) [7][14].
  • The Pathology Report: If you have had a bone marrow biopsy, bring the full pathology report. If possible, ask your original hospital for the physical slides or tissue blocks so the specialist’s team can re-examine them [11][15].
  • Genetic Results: Bring the specific results of your KIT test. It’s important for the doctor to know if it was done on blood or bone marrow and the sensitivity of the test used (e.g., ddPCR vs. NGS) [16][17].
  • Reaction Diary: A summary of your reaction history. Include dates, suspected triggers, specific symptoms, and what interventions were required [18][19].

By building this team and providing them with clear records, you move from being a patient who is “reacting” to a patient who is “proactive” [20][10].

Common questions in this guide

Which doctors should be involved in care for MMAS?
A hematologist evaluates the clonal mast cell process, including bone marrow findings, the KIT D816V genetic change, CD25 markers, and blood counts. An allergist or immunologist manages reactions, epinephrine, venom allergy, and symptom medicines. Primary care and, when needed, gastroenterology, endocrinology, hematopathology, and anesthesiology can add coordinated care.
What records should I bring to my first MMAS specialist appointment?
Bring a dated list of tryptase results, marking which tests were done when you felt well and which were done during or soon after a reaction. Also bring the complete bone marrow pathology report, available slides or tissue blocks, KIT results with the sample type and test method, and a reaction diary describing triggers, symptoms, and treatments.
Can a negative KIT blood test rule out MMAS?
Not necessarily. A peripheral blood test may not provide the same information as a highly sensitive test on bone marrow, so a hematologist should interpret it alongside symptoms, tryptase results, and other findings. Ask whether additional testing is appropriate for your clinical picture.
How should I prepare for surgery if I have MMAS?
Tell the surgeon and anesthesiologist about MMAS well before the procedure, and ask them to coordinate with your allergist or immunologist. The team should create an individualized plan for medications, anesthetic choices, monitoring, and rescue treatment. Do not self-premedicate or change your medication without explicit medical instructions.
What should an MMAS emergency plan include?
Your allergist or immunologist should help create an emergency summary that includes your anaphylaxis history, prescribed epinephrine dose, and emergency contacts. Keep it accessible and share it with the clinicians involved in your care.
Why might a mast cell specialist review my bone marrow slides?
A hematopathologist experienced in mast cell disorders can review biopsy tissue, slides, and tissue blocks for subtle or difficult-to-see clonal mast cell findings. Expert review may clarify an uncertain initial interpretation and help guide the next steps in evaluation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How do my hematologist, allergist, and primary care provider communicate to coordinate my care?
  2. 2.Does your clinic or laboratory have expertise in identifying subtle or 'morphologically occult' mast cell disease?
  3. 3.If my initial peripheral blood KIT test was negative, does my clinical picture warrant a high-sensitivity test on a bone marrow sample?
  4. 4.Can you recommend specialists (e.g., gastroenterology, endocrinology) who have experience treating mast cell patients?
  5. 5.Is there a mastocytosis reference center you can refer me to for a second opinion on my pathology?
  6. 6.How will you coordinate with my anesthesiologist to create a safe perioperative plan for future surgeries?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

    González-de-Olano D, Matito A, Orfao A, Escribano L

    F1000Research 2016; (5()):2666 doi:10.12688/f1000research.9565.1.

    PMID: 27909577
  2. 2

    [Mast cell activation syndrome. About a clinical case].

    Cardona R, Muñoz-Ávila MA, Gómez-Henao C, et al.

    Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2019; (66(4)):504-509 doi:10.29262/ram.v66i4.587.

    PMID: 32105433
  3. 3

    Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders.

    Muñoz-González JI, García-Montero AC, Orfao A, Álvarez-Twose I

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2021; (127(4)):427-434 doi:10.1016/j.anai.2021.07.014.

    PMID: 34298172
  4. 4

    NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024.

    Gotlib J, Gerds AT, Abdelmessieh P, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2024; (22(2 D)).

    PMID: 38862005
  5. 5

    Precision Medicine in Systemic Mastocytosis.

    Nicolosi M, Patriarca A, Andorno A, et al.

    Medicina (Kaunas, Lithuania) 2021; (57(11)) doi:10.3390/medicina57111135.

    PMID: 34833353
  6. 6

    KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis.

    Reiter A, Rossignol J, Deininger MW, et al.

    The journal of allergy and clinical immunology. In practice 2026; (14(1)):44-52 doi:10.1016/j.jaip.2025.10.034.

    PMID: 41187902
  7. 7

    Diagnosis and management of mast cell activation syndrome (MCAS) in Canada: a practical approach.

    Lee E, Picard M

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2025; (21(1)):49 doi:10.1186/s13223-025-00998-9.

    PMID: 41272881
  8. 8

    Mast Cell Disorders and Hymenoptera Venom-Triggered Anaphylaxis: Evaluation and Management.

    Boggs NA, Tanasi I, Hartmann K, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(1)):40-48 doi:10.1016/j.jaip.2024.08.034.

    PMID: 39187156
  9. 9

    Systemic Mastocytosis: Multidisciplinary Approach.

    Zanotti R, Tanasi I, Crosera L, et al.

    Mediterranean journal of hematology and infectious diseases 2021; (13(1)):e2021068 doi:10.4084/MJHID.2021.068.

    PMID: 34804442
  10. 10

    Definition of Competencies for Allergology Specialty/Subspecialty Training in Mast Cell Disorders in Europe: An EAACI Position Paper.

    Rama TA, Gulen T, Brockow K, et al.

    Allergy 2026; (81(8)):2713-2725 doi:10.1111/all.70344.

    PMID: 42037259
  11. 11

    Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.

    Jawhar M, Schwaab J, Horny HP, et al.

    European journal of clinical investigation 2016; (46(5)):392-7 doi:10.1111/eci.12607.

    PMID: 26914980
  12. 12

    Gastrointestinal Involvement in Mast Cell Activation Disorders.

    Hsieh FH

    Immunology and allergy clinics of North America 2018; (38(3)):429-441 doi:10.1016/j.iac.2018.04.008.

    PMID: 30007461
  13. 13

    The Prevalence Of Osteoporosis Is Low in Adult Cutaneous Mastocytosis Patients.

    Degboé Y, Severino-Freire M, Couture G, et al.

    The journal of allergy and clinical immunology. In practice 2024; (12(5)):1306-1312 doi:10.1016/j.jaip.2024.02.021.

    PMID: 38423295
  14. 14

    Tryptase values in anaphylaxis and insect allergy.

    Bonadonna P, Scaffidi L, Boni E

    Current opinion in allergy and clinical immunology 2019; (19(5)):462-467 doi:10.1097/ACI.0000000000000569.

    PMID: 31306180
  15. 15

    Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis.

    Reichard KK, Chen D, Pardanani A, et al.

    American journal of clinical pathology 2015; (144(3)):493-502 doi:10.1309/AJCPSGQ71GJQQACL.

    PMID: 26276780
  16. 16

    High-sensitivity KIT D816V variation analysis by droplet digital polymerase chain reaction: The reference laboratory perspective.

    Shean RC, Hellwig S, Saadalla A, et al.

    American journal of clinical pathology 2025; (164(2)):145-149 doi:10.1093/ajcp/aqaf008.

    PMID: 40036308
  17. 17

    Confirmed Systemic Mastocytosis in a Pediatric Patient With Widespread Cutaneous Symptoms.

    Cahill JA, Suresh S, Livingston JR

    Pediatrics 2025; doi:10.1542/peds.2024-067915.

    PMID: 39904361
  18. 18

    Venom Anaphylaxis: Decision Points for a More Aggressive Workup.

    Bonadonna P, Korosec P, Nalin F, Golden DBK

    The journal of allergy and clinical immunology. In practice 2023; (11(7)):2024-2031 doi:10.1016/j.jaip.2023.04.016.

    PMID: 37119981
  19. 19

    Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).

    Ruëff F, Bauer A, Becker S, et al.

    Allergologie select 2023; (7()):154-190 doi:10.5414/ALX02430E.

    PMID: 37854067
  20. 20

    Anaphylaxis: A 2023 practice parameter update.

    Golden DBK, Wang J, Waserman S, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2024; (132(2)):124-176 doi:10.1016/j.anai.2023.09.015.

    PMID: 38108678

This page explains how to organize care and prepare for monoclonal mast cell activation syndrome visits for informational purposes only and does not constitute medical advice. Do not change medicines or premedicate before a procedure without guidance from your treating clinicians.

Get notified when new evidence is published on Monoclonal mast cell activation syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.